Poseida Therapeutics Inc (PSTX)
US$ 2.864.76%
Price Chart
Key Statistics
Market Cap
$ 925.93M
P/E Ratio
0.00
Revenue (TTM)
$ 150.86M
Volume
286.32K
52W High
$ 9.67
52W Low
$ 2.32
Dividend Yield
0.00%
Beta
0.54
Technicals
50-Day MA
7.2286
200-Day MA
3.945
52 Week High
9.67
52 Week Low
2.32
About PSTX
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs.
Employees
350
Headquarters
San Diego, CA
CEO
Mr. Mark J. Gergen J.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg